593622 Disclosed is a solid unit dosage form for oral administration, wherein the unit dosage is in the form of a minitablet having a size of between 1 mm and 4 mm and having a core and an outer coating, wherein: the core comprises between about 2 mg and about 4 mg of aliskiren, or a pharmaceutically acceptable salt thereof and the outer coating is in the form of a film-coat which comprises a taste masking material selected from polyacrylates, and/or a modified release coating component selected from cellulose derivatives and acrylic copolymers, and mixtures thereof, for use in the treatment of hypertension, congestive heart failure, angina, myocardial infarction, atherosclerosis, diabetic nephropathy, diabetic cardiac myopathy, renal insufficiency, peripheral vascular disease, left ventricular hypertrophy, cognitive dysfunction, stroke, headache and chronic heart failure.
